PROPENSITY SCORE ADJUSTED REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB VS. ANTI-TNF IN BIOLOGIC-NAÏVE CROHN´S DISEASE PATIENTS: INDUCTION PHASE RESULTS FROM THE PROSPECTIVE, OBSERVATIONAL VEDOIBD STUDY IN GERMANY

Bernd Bokemeyer  1     Sandra Plachta-Danielzik  2     Romina di Giuseppe  2     Philipp Efken  3     Wolfgang Mohl  4     Martin Hoffstadt  5     Thomas Krause  6     Axel Schweitzer  7     Elisabeth Schnoy  8     Raja Atreya  9     Niels Teich  10     Leo Trentmann  11     Robert Ehehalt  12     Sina Franzenburg  12     Petra Hartmann  12     Stefan Schreiber  13    
1 Interdiscilinary Crohn Colitis Centre Minden, Minden, Germany
2 Competence Network IBD, Kiel, Germany
3 Gastroenterology Practice Minden, Minden, Germany
4 Zentrum fur Gastroenterologie Saar MVZ GmbH, Saarbrücken, Germany
5 Medizinisches Versorgungszentrum Dres. Hoffstadt, Iserlohn, Germany
6 Gastroenterology Practice Kassel Opernstraße, Kassel, Germany
7 Gastroenterologische Gemeinschaftspraxis am Germania Campus, Münster, Germany
8 Universitätsklinikum Augsburg, Augsburg, Germany
9 University Erlangen-Nuremberg, Erlangen, Germany
10 Gastroenterology Practice Leipzig, Leipzig, Germany
11 Gastroenterology Practice Bremen, Bremen, Germany
12 Praxis für Gastroenterologie Prof. Dr. R. Ehehalt, Heidelberg, Germany
13 Universität Kiel UKSH Medizinische Abt. I, Kiel, Germany

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing